Gout management and outcomes during established COVID-19 pandemic in 2020-2021: a cross-sectional Internet survey

Jasvinder A Singh1, N Lawrence Edwards2

  • 1Department of Medicine, School of Medicine, University of Alabama, Faculty Office Tower 805B, 510 20th Street S, Birmingham, AL 35294, USA.

Insights

Gout patients faced challenges managing their condition during the COVID-19 pandemic, including healthcare access issues and psychological distress. Moderate-severe psychological distress significantly worsened difficulties in healthcare access and overall gout management.

Area of Science:

  • Rheumatology and Immunology
  • Public Health and Epidemiology
  • Psychological Medicine

Background:

  • The COVID-19 pandemic significantly disrupted healthcare systems globally.
  • Gout management requires consistent medical care and medication adherence, both potentially impacted by pandemic-related challenges.

Purpose of the Study:

  • To evaluate the management of gout during the established COVID-19 pandemic.
  • To assess medication use, healthcare utilization, quality of life, and psychological factors in gout patients during the pandemic.

Main Methods:

  • A cross-sectional internet survey was conducted among individuals with physician-diagnosed, self-reported gout.
  • Data collected included medication use (urate-lowering therapy - ULT), healthcare access, gout-specific health-related quality of life (HRQOL), psychological distress (PHQ-4), resilience, illness perception, and health literacy.

Main Results:

  • Among 130 respondents, 59% were prescribed ULT, and 80% had adequate health literacy.
  • A third reported increased difficulty managing gout post-September 2020, with evident HRQOL deficits.
  • Moderate-severe psychological distress (22% of respondents) was significantly associated with increased difficulties in accessing healthcare, managing gout flares, avoiding complications, and performing daily/work activities.

Conclusions:

  • Gout patients experienced healthcare gaps, suboptimal ULT prescription rates, elevated psychological distress, and reduced HRQOL during the pandemic.
  • Psychological distress emerged as a key factor exacerbating difficulties in healthcare access and gout management.
  • Targeted interventions are crucial to address these multifaceted challenges in gout patient care during public health crises.
Abstract

Related Concept Videos

Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
521
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
30
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
39
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
39
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
56
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
33